The hypermethylation at −658 and −793 CpGs of the CTLA-4 promoter has been indicated to be associated with MG by decreasing the frequency of Treg cells and CTLA-4+ Treg cells (147). This evidence concerns the gene CTLA4 and myasthenia gravis.